Catheter Stabilization Devices Market Size was valued at USD 1.48 Billion in 2023 and is expected to reach USD 2.77 billion by 2032, growing at a CAGR of 7.22% over the forecast period 2024-2032.
This report provides key statistical insights and emerging trends shaping the Catheter Stabilization Devices Market. It emphasizes on increasing incidence of catheterization and complications associated with it, which would generate demand for securement devices. Increased acceptance in North America and Europe means regional prescription trends will show higher adoption because of stricter infection control protocols. Reporting on device volume growth, it shows a continued increase in demand globally. It also analyzes expenditure patterns across public, private, and out-of-pocket segments. It also highlights stabilization device importance in minimizing the risk of hospital-acquired infections and assesses the regulatory landscape in prominent geographies. These insights collectively reflect the market’s evolving landscape, technological adoption, and growing importance of patient safety and care efficiency.
The increasing incidence of chronic disease conditions such as cardiovascular diseases, cancer, and neurological disorders, which require catheter placement for treatment, is driving the growth of the catheter stabilization devices market. The catheter stabilization devices market in the USA has observed steady year-on-year growth, increasing from USD 0.40 billion to USD 0.74 billion in a decade. This reflects a compound annual growth rate (CAGR) of 7.12%, driven by increasing hospital admissions, stringent safety protocols, and a strong focus on reducing catheter-related complications. The surge indicates strong demand backed by public and private healthcare spending in India. For example, the Centers for Disease Control and Prevention (CDC) states that, in the United States, more than 300 million catheters are used each year, of which almost 3 million are central venous catheters.
Drivers
The increasing prevalence of chronic diseases, such as cardiovascular conditions and cancer, necessitates catheterization procedures, thereby boosting the demand for catheter stabilization devices.
The growing prevalence of chronic diseases across the globe is a key factor propelling the growth of the catheter stabilization devices market. Cardiovascular diseases (CVDs) are the leading cause of death worldwide, with ischemic heart disease accounting for approximately 9.1 million deaths 13% of total deaths that occurred in 2021. As of 2021, approximately 6.9% of the adult population in OECD countries suffer from diabetes, and the condition can give rise to several complications, which frequent catheterization procedures can help address. Chronic obstructive pulmonary disease (COPD) is another major global health burden, affecting about 213 million people or 2.7% of the population worldwide, and contributing to 3.65 million deaths in 2021. The growing prevalence of these chronic diseases has led to an increase in the number of patients undergoing medical procedures that require the use of catheters, including intravenous therapies, dialysis, and cardiac interventions. As a result, the need for catheter stabilization devices has increased, as these devices play a critical role in securing catheters, reducing complications such as dislodgement or infection, and promoting effective treatment administration. This trend underscores the critical role of catheter stabilization devices in managing the healthcare needs of a population increasingly affected by chronic diseases.
Restraint
The availability of alternative products, like dressing tapes, presents cost-effective options that may limit the adoption of specialized catheter stabilization devices.
The catheter stabilization devices market faces notable challenges due to the availability of alternative securement methods, particularly adhesive dressings and tapes. These alternatives are often perceived as more cost-effective, leading healthcare providers to favor them over specialized stabilization devices. This preference is especially pronounced in regions with constrained healthcare budgets, where cost considerations heavily influence procurement decisions. While adhesive dressings and tapes may offer initial cost savings, they can be associated with higher rates of catheter-related complications, such as dislodgement and infection. For instance, a study comparing various securement methods found that certain investigational devices displayed higher mean peak axial pull forces (40–41 N) compared to sutures (28 N) and securement dressings (17 N), indicating superior catheter stabilization. Despite the clinical advantages of specialized stabilization devices, their higher upfront costs can deter widespread adoption, particularly in cost-sensitive healthcare settings. This economic restraint underscores the need for comprehensive cost-benefit analyses to demonstrate the long-term value of catheter stabilization devices in reducing complications and associated healthcare costs.
Opportunity
The rising trend of home-based healthcare and remote patient monitoring opens avenues for catheter stabilization devices designed specifically for homecare settings.
The global shift towards home-based healthcare and remote patient monitoring is significantly influencing the demand for catheter stabilization devices tailored for home settings. As healthcare systems aim to reduce hospital stays and manage chronic conditions more effectively, the emphasis on home care has intensified. For instance, in the United States, approximately 3 million central venous catheters are utilized annually, underscoring the widespread need for effective catheter management across various settings, including homes. Similarly, the Asia-Pacific region is experiencing rapid growth in the catheter stabilization market, driven by increasing healthcare expenditure and a rising prevalence of chronic diseases. These trends highlight the growing necessity for catheter stabilization devices that are user-friendly and safe for home use, enabling patients to manage their conditions effectively outside traditional healthcare facilities. Manufacturers are thus presented with the opportunity to innovate and develop products that cater specifically to the home healthcare market, addressing both patient comfort and safety.
Challenge
Navigating stringent regulatory requirements for medical devices can pose challenges for market entry and product commercialization, especially for small and medium-sized manufacturers.
The regulatory landscape is complex for manufacturers of catheter stabilization devices. Furthermore, the lack of shared regulations around the globe means companies have to adapt their compliance to different and changing standards, resulting in greater complication and resource allocation. According to a 2024 recent survey in Europe, more than 50% of the time an organization spends on the conformity assessment is used up in pre-review and certificate issuing processes rather than the review phase itself, revealing inefficiencies in the regulatory framework. In addition, the EU MDR has introduced significant compliance costs and timelines for medical device certifications, with an average processing time of 18 months. Moreover, the combined effect of these points affects the financial and operational resources, especially for the small and medium enterprises (SMEs), leading to an innovation bottleneck and time-to-market delays in the catheter stabilization technologies. While it is important to recognize the challenges, efforts like the International Medical Device Regulators Forum (IMDRF) are driving convergence through programs such as the Medical Device Single Audit Program (MDSAP), where a single audit may be recognized by multiple regulators. However, despite these efforts, achieving global harmonization remains a complex and gradual process, requiring ongoing collaboration among international regulatory bodies to streamline compliance pathways and facilitate market access for medical device manufacturers.
By Product
The arterial securement devices segment accounted for the largest share of the market in 2023 due to the crucial nature of their application in cardiovascular procedures. Factors like the increasing incidence of cardiovascular diseases worldwide contribute to a rise in arterial catheterizations. As still a leading cause of morbidity globally, they require advanced medical interventions, according to government data. These devices ensure secure placement during arterial catheterization, reducing risks such as dislodgement or infection. This segment has also been further bolstered by technological advancements. For instance, adapters have been created with improved adhesive strength and antimicrobial distractions in manufacturing for arterial securement to reduce complications. In addition, increased utilization of arterial catheters in minimally invasive surgeries has led to an increase in the uptake of these devices. In North America alone, arterial securement devices accounted for substantial revenue due to high procedural volumes and advanced healthcare systems. Emerging markets are also contributing to this segment's growth. There is a rapid increase in cardiovascular interventions in the Asia-Pacific due to lifestyle-related diseases as well as developing healthcare infrastructure. An increase in geographically rooted government initiatives aimed at ensuring access to healthcare and educating people about infection prevention has also been contributing to the wide demand for arterial securement devices across the world.
By End Use
In 2023, hospitals accounted for the largest share of the catheter stabilization devices market at 58%, owing to the high usage of these devices in inpatient and outpatient procedures. Hospital procedures include countless surgeries in which a catheter is needed for drug delivery or drainage. According to the American Nurses Association (ANA), over 560,000 patients acquire CAUTIs annually in hospital settings, highlighting the need for effective stabilization devices to reduce infection risks.
The rising incidence of hospital-acquired infections (HAIs) has fueled demand for innovative catheter stabilization solutions. These minimize complications like CLABSIs and patient safety by preventing dislodged. As a result, there is a growing trend among hospitals towards the adoption of innovative products that possess antimicrobial properties to effectively tackle these challenges. Increased growth in hospital infrastructures in developing regions has fuelled growth in this segment. To meet increasing patient flows and the omnipresence of chronic diseases, governments are pouring huge sums into healthcare facilities. For example, hospitals in the Asia-Pacific region are improving their capabilities with advanced devices and technologies, which, in turn, is increasing the demand for catheter stabilization devices.
In 2023, North America remained the leading region in the catheter stabilization devices market and held a share of nearly 36% of the global market. The dominance of this region can be attributed to several factors such as the high volume of surgical procedures necessitating catheterization, advanced healthcare infrastructure, and high adoption rate of innovative catheter securement solutions. The United States is a key player in this predominance, with the Joint Commission estimating that there are nearly 3 million central venous catheters used each year of the estimated 300 million catheterizations performed in the U.S. The region’s market growth is also supported by favorable government initiatives and stringent healthcare policies to curb catheter-associated infections. The catheter stabilization devices market across Europe is also expected to held a significant share owing to the growing aging population in the region, along with a surge in lifestyle-derived medical conditions such as cardiovascular disorders. Germany, the UK, and France are among the top contributors. Germany is at the forefront of providing advanced manufacturing capabilities for medical devices, and the UK is focused on developing innovative techniques to prevent catheter-related bloodstream infections (CRBSIs). France emphasizes cost-effective solutions in public healthcare settings.
Asia-Pacific emerged as the fastest-growing region with a significant compound annual growth rate (CAGR) during the forecast period. Factors responsible for the growth of the factor are the high healthcare spending, infection prevention awareness levels, and the rising amount of surgical procedures being conducted owing to numerous chronic diseases. The region is dominated by China, with developing healthcare facilities and government initiatives aimed at enhancing patient safety standards. India and Japan also make considerable contributions: India is experiencing a rise in catheterization procedures used in critical care and neonatal applications, while Japan focuses on providing advanced medical technologies accompanied by securement solutions.
3M Company (Tegaderm IV Securement Device, PICC CVC Securement Device)
B. Braun Melsungen AG (Certofix Securement Device, Introcan Safety)
Becton, Dickinson and Company (BD) (StatLock Stabilization Device, MaxZero Extension Set)
Medtronic plc (SecurePortIV Catheter Securement, MiniMed Infusion Sets)
Smiths Medical (ICU Medical) (CADD Catheter Securement System, Jelco IV Catheters)
Cardinal Health, Inc. (CVP Securement Device, IV3000 Securement Dressing)
ConvaTec Group plc (AQUACEL Ag Advantage Securement, DuoDERM Extra Thin Dressing)
TIDI Products, LLC (Grip-Lok Securement Devices, Sterile Securement Tabs)
Centurion Medical Products (Medline) (SecurAcath Securement, Sorbaview Shield)
Mölnlycke Health Care AB (Mepilex Border Post-Op, Mepore Film and Pad)
DeRoyal Industries, Inc. (CathGrip Securement, DEHP-Free Securement Tape)
NeoMed, Inc. (NeoSecure Securement Devices, NeoBridge Tube Holder)
Marpac Inc. (Tracheostomy Tube Holder, ET Tube Holder)
Halyard Health (Owens & Minor) (MIC-KEY Securement, Halyard Securement Dressings)
Smith & Nephew plc (IV3000 Film Dressing, Opsite Post-Op Visible)
Dale Medical Products, Inc. (Stabilock, Hold-n-Place)
C.R. Bard, Inc. (BD) (StatLock PICC Plus, StatLock Foley Stabilization)
Marlen Manufacturing & Development Co. (UltraMax Securement, Catheter Strip Securement)
Interrad Medical, Inc. (SecurAcath Securement System, SecurCath Extended Dwell)
MedSecure Products (CathSecure Advanced, CathGrip Pro)
In April 2023, ConvaTec purchased an anti-infective nitric oxide technology platform to expand its portfolio in the area of infection prevention.
In September 2022, B. Braun Medical Inc. acquired the Clik-FIX catheter securement device product portfolio from Starboard Medical to bolster its peripheral intravenous (IV) therapy business.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 1.48 Billion |
| Market Size by 2032 | USD 2.77 Billion |
| CAGR | CAGR of 7.22% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Products (Arterial Securement Devices, Chest Drainage Tube Securement Devices, Peripheral Securement Devices, Central Venous Catheter Securement Devices, Urinary Catheter Securement Devices, Others) • By End-use (Hospitals, Home Care Settings, Others |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | 3M Company, B. Braun Melsungen AG, Becton, Dickinson and Company (BD), Medtronic plc, Smiths Medical (ICU Medical), Cardinal Health, Inc., ConvaTec Group plc, TIDI Products, LLC, Centurion Medical Products (Medline), Mölnlycke Health Care AB, DeRoyal Industries, Inc., NeoMed, Inc., Marpac Inc., Halyard Health (Owens & Minor), Smith & Nephew plc, Dale Medical Products, Inc., C.R. Bard, Inc. (BD), Marlen Manufacturing & Development Co., Interrad Medical, Inc., MedSecure Products |
Ans. The projected market size for the Catheter Stabilization Devices Market is USD 2.7 billion by 2032.
Ans: The North American region dominated the Catheter Stabilization Devices Market in 2023.
Ans. The CAGR of the Catheter Stabilization Devices Market is 7.22% during the forecast period of 2024-2032.
Ans: The rising trend of home-based healthcare and remote patient monitoring opens avenues for catheter stabilization devices designed specifically for home care settings. ?
Ans: The hospital segment dominated the Catheter Stabilization Devices Market.
Table of Content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence & Prevalence of Catheter Use (2023)
5.2 Prescription and Utilization Trends by Region (2023)
5.3 Device Volume and Demand Forecast (2020–2032)
5.4 Hospital-Acquired Infection (HAI) Reduction Initiatives
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Catheter Stabilization Devices Market Segmentation, By Products
7.1 Chapter Overview
7.2 Arterial Securement Devices
7.2.1 Arterial Securement Devices Market Trends Analysis (2020-2032)
7.2.2 Arterial Securement Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Chest Drainage Tube Securement Devices
7.3.1 Chest Drainage Tube Securement Devices Market Trends Analysis (2020-2032)
7.3.2 Chest Drainage Tube Securement Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Peripheral Securement Devices
7.3.1 Peripheral Securement Devices Market Trends Analysis (2020-2032)
7.3.2 Peripheral Securement Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Central Venous Catheter Securement Devices
7.3.1 Central Venous Catheter Securement Devices Market Trends Analysis (2020-2032)
7.3.2 Central Venous Catheter Securement Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Urinary Catheter Securement Devices
7.3.1 Urinary Catheter Securement Devices Market Trends Analysis (2020-2032)
7.3.2 Urinary Catheter Securement Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Others
7.3.1 Others Market Trends Analysis (2020-2032)
7.3.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Catheter Stabilization Devices Market Segmentation, By End-use
8.1 Chapter Overview
8.2 Hospitals
8.2.1 Hospitals Market Trends Analysis (2020-2032)
8.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Home Care Settings
8.3.1 Home Care Settings Market Trends Analysis (2020-2032)
8.3.2 Home Care Settings Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Others
8.4.1 Others Market Trends Analysis (2020-2032)
8.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Catheter Stabilization Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.2.4 North America Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.2.5.2 USA Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.2.6.2 Canada Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.2.7.2 Mexico Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Catheter Stabilization Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.3.1.5.2 Poland Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.3.1.6.2 Romania Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Catheter Stabilization Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.3.2.4 Western Europe Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.3.2.5.2 Germany Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.3.2.6.2 France Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.3.2.7.2 UK Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.3.2.8.2 Italy Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.3.2.9.2 Spain Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.3.2.12.2 Austria Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Catheter Stabilization Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.4.4 Asia Pacific Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.4.5.2 China Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.4.5.2 India Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.4.5.2 Japan Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.4.6.2 South Korea Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.2.7.2 Vietnam Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.4.8.2 Singapore Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.4.9.2 Australia Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Catheter Stabilization Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.5.1.4 Middle East Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.5.1.5.2 UAE Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Catheter Stabilization Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.5.2.4 Africa Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.2.7 Rest of Africa
9.5.2.7.1 Rest of Africa Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.5.2.7.2 Rest of Africa Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Catheter Stabilization Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.6.4 Latin America Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.6.5.2 Brazil Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.6.6.2 Argentina Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.6.7.2 Colombia Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Catheter Stabilization Devices Market Estimates and Forecasts, By Products (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Catheter Stabilization Devices Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10. Company Profiles
10.1 3M Company
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
110.1.4 SWOT Analysis
10.2 B. Braun Melsungen AG
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Becton, Dickinson and Company (BD)
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Medtronic plc
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Smiths Medical (ICU Medical)
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Cardinal Health, Inc.
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 ConvaTec Group plc
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 TIDI Products, LLC
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Centurion Medical Products (Medline)
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Mölnlycke Health Care AB
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Products
Arterial Securement Devices
Chest Drainage Tube Securement Devices
Peripheral Securement Devices
Central Venous Catheter Securement Devices
Urinary Catheter Securement Devices
Others
By End-use
Hospitals
Home Care Settings
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The HIV Diagnostics Market Size was valued at USD 1.15 billion in 2023, expected to reach USD 1.80 billion by 2032 and grow at a CAGR of 5.10% from 2024-2032.
The Digital Pathology Market size is expected to reach USD 2.92 billion by 2032 from USD 1.01 billion in 2023 and grow at CAGR of 12.54% over the forecast period 2024-2032.
Medical Image Management Market was valued at USD 4.88 billion in 2023 and is expected to reach USD 9.06 billion by 2032, growing at a CAGR of 7.18% from 2024-2032.
Glycomics Market was valued at USD 1.68 billion in 2023 and is expected to reach USD 5.33 billion by 2032, growing at a CAGR of 13.76% from 2024 to 2032.
The Anastomosis Devices Market Size was valued at USD 3.61 billion in 2023 and is expected to reach USD 6.63 billion by 2032 and grow at a CAGR of 7.01% over the forecast period 2024-2032.
Breathalyzers Market was valued at USD 2.7 billion in 2023 and is expected to reach USD 10.9 billion by 2032, growing at a CAGR of 16.74% from 2024 to 2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
